In the News

Turning Away a Patent Challenge: The NHK-Fintiv Rule Explained (Bloomberg Law)

Bloomberg Law, March 3, 2021

Turning Away a Patent Challenge: The NHK-Fintiv Rule Explained

The New York City Bar Association noted Hatch-Waxman lawsuits, which involve disputes between brand-name and generic drug makers, and ITC cases are likely to be ‘disproportionately affected’ under the current approach.

Read more